In operating rooms around the world, the last minutes of a child’s anesthesia follow a script so familiar it is almost choreographed. The vaporizer clicks off, the surgeons begin to close, and the anesthesiologist — often without conscious thought — turns the inspired oxygen up toward 100 percent. The rationale is woven into generations of teaching: flood the child’s lungs with a rich reserve of oxygen so that the turbulent minutes of waking, coughing, breath-holding and suctioning pass without a dangerous dip in blood oxygen. Yet a randomized controlled trial published on 29 August 2026 in the journal Pediatric Research, in which a team led by Gupta and colleagues tested one of anesthesia’s most ingrained habits, asks a question that unsettles this reflex: does the very maneuver designed to protect a child on the way out of anesthesia quietly set the stage for collapsed lungs on the ward afterwards?

At the center of the trial lies a phenomenon that sounds like a paradox: oxygen, the molecule that sustains every cell in a child’s body, can behave in a way that deflates the microscopic air sacs it is meant to sustain. The researchers randomly assigned children undergoing surgery under general anesthesia to different oxygen strategies in the final phase before extubation — the moment the breathing tube is removed — and tracked the incidence of postoperative atelectasis, the partial or complete collapse of lung units that had been held open during the operation. The premise, stated plainly in the paper, is unambiguous. A high fraction of inspired oxygen, the FiO2 that anesthesiologists dial up with a single knob, leads to absorption atelectasis during general anesthesia, and that collapse can cascade into decreased lung compliance, increased intrapulmonary shunt, increased pulmonary vascular resistance, hypoxemia and lung injury.

The physics behind absorption atelectasis begins with a gas most people ignore: nitrogen. Roughly 78 percent of every normal breath is nitrogen, an inert gas that crosses into the bloodstream only reluctantly. That reluctance is not a flaw but a structural feature of human respiration. Nitrogen lingers in the alveoli — the grape-like clusters of air sacs where oxygen meets blood — and behaves like thousands of microscopic splints holding the sacs open. When the inspired oxygen fraction climbs toward 1.0, those splints are flushed away in a process called denitrogenation. Each alveolus continuously transfers oxygen into the pulmonary capillaries while carbon dioxide diffuses out, and in a normally ventilated lung fresh gas refills the sac as fast as the blood removes it. But under general anesthesia, dependent regions of the lung lose ventilation: small airways close, and trapped alveoli are fed only by the oxygen-rich gas already inside them. Blood keeps extracting that oxygen, and with no nitrogen reserve to hold the sac’s volume steady, the alveolus shrinks and collapses, sometimes within minutes. The same alveolus filled with room air resists collapse far longer, because its nitrogen content simply persists.

Once alveoli collapse, the consequences ripple through the entire cardiopulmonary system. Collapsed lung units contribute nothing to gas exchange yet remain perfused, so deoxygenated blood streams past them and mixes with oxygenated blood leaving healthier regions — the intrapulmonary shunt the trial’s authors flag as a downstream cost. This venous admixture produces hypoxemia that is notoriously stubborn, because the problem is blood bypassing ventilated lung altogether rather than a shortage of oxygen in the airways. At the same time the lung loses compliance: it stiffens, airway pressures rise during ventilation, and the work of breathing climbs. Widespread collapse also raises pulmonary vascular resistance as hypoxic vessels constrict and mechanical forces compress the vasculature, adding load to the right side of the heart. Nor does the injury stop at mechanics. Alveoli that repeatedly snap open and shut suffer atelectrauma, shear-driven damage to their delicate epithelial lining, while sustained hyperoxia generates reactive oxygen species that can inactivate surfactant, the soap-like film that keeps small alveoli from collapsing under their own surface tension.

For a child on a surgical ward, atelectasis is not an abstract measurement. It is among the most common pulmonary complications after general anesthesia in pediatric practice, and its fingerprints are familiar to any postoperative team: a patchy shadow on imaging, a fall in oxygen saturation, a cough that will not settle, a fever that muddies the clinical picture, an unanticipated need for supplemental oxygen overnight. Most episodes resolve as the child breathes deeply, cries, coughs and moves in the days after surgery. But some do not. Atelectasis can seed lower respiratory infections, prolong oxygen therapy, extend hospital stays and, in vulnerable children — infants, former preterm babies, those with pre-existing lung disease — escalate into genuine respiratory distress requiring intensive care. Quantifying how much of this burden traces back to decisions made in the final minutes of anesthesia is precisely the gap the new randomized controlled trial was designed to close.

Children, moreover, are not simply small adults, and it is the trial’s pediatric focus that gives it weight. Young children operate with a functional residual capacity — the oxygen reservoir that remains in the lungs at the end of a normal exhale — that is meager relative to their metabolic hunger. Infants consume roughly twice as much oxygen per kilogram of body weight as adults, which is why a sedated baby can desaturate with alarming speed. In early childhood the closing capacity of the lungs, the volume at which small airways begin to shut, encroaches on ordinary tidal breathing, leaving dependent alveoli perilously close to collapse even in health. The collateral ventilation channels that let gas slip between neighboring alveoli in mature lungs — the pores of Kohn and channels of Lambert — are poorly developed in the young, so a sealed-off alveolus has no rescue route. Add a highly compliant chest wall with horizontally angled ribs, weak intercostal musculature, and the reduction in lung volume that general anesthesia itself produces, and the pediatric lung sits far closer to the edge of collapse than the adult lung ever does.

None of this means pre-extubation oxygenation is foolish; it exists because emergence from anesthesia is genuinely dangerous. As a child stirs, protective reflexes return erratically. Coughing, biting, breath-holding and laryngospasm — the abrupt glottic clamping that can shut the airway entirely — all threaten to interrupt ventilation at the very moment the tube comes out, and secretions suctioned from the airway remove lung volume along with mucus. A lung pre-filled with nearly pure oxygen carries a reserve that buys precious seconds; a lung left on room air offers only a fraction of that buffer, and seconds matter when a toddler’s saturation can plummet in under a minute. The trial does not deny this protective logic. What it does is force a reckoning with the price: the oxygen reserve that shields a child during emergence may be built by flushing out the nitrogen that would otherwise keep alveoli stable, converting a momentary safety advantage into a postoperative liability measured in collapsed lung units.

The debate over perioperative oxygen has been running in adult medicine for decades. Classic computed tomography studies showed that most adults under general anesthesia develop some degree of atelectasis within minutes of induction, and that breathing near-pure oxygen enlarges those collapsed zones. At the same time, high inspired oxygen has enjoyed powerful institutional backing: international guidelines have recommended high perioperative oxygen concentrations for intubated adults to reduce surgical-site infections, a recommendation that later trials and meta-analyses have repeatedly challenged. Anesthesiologists have countered the collateral damage with positive end-expiratory pressure and recruitment maneuvers that pop closed alveoli back open, but the pediatric evidence base remained thin, because children are routinely excluded from large perioperative trials. By testing the question directly in children with the methodological gold standard of randomization, the new study supplies the discipline-specific evidence that adult data cannot simply be extrapolated to provide.

For clinicians, the study reinforces a principle gaining ground across critical care and anesthesiology: oxygen is a drug, with a dose, a timing and side effects of its own, not an all-purpose safety fluid to be maximized by reflex. In practice that means tailoring the inspired oxygen fraction in the minutes before extubation rather than defaulting to the top of the dial, weighing each child’s risk of a stormy emergence against the risk of postoperative lung collapse, and pairing whatever oxygen strategy is chosen with maneuvers that preserve alveolar stability. It does not mean abandoning preoxygenation for the children who need it; a patient with a tenuous airway, obesity, a recent respiratory infection or compromised cardiac reserve may still warrant a generous oxygen buffer. It means the fraction of inspired oxygen joins the long list of variables anesthesiologists already individualize — drug doses, ventilation pressures, fluid choices — according to age, weight and physiology.

The trial also sketches the agenda for what must come next. Future studies will need to define which children benefit most from conservative oxygen strategies, whether infants behave differently from older children, how the timing and duration of high inspired oxygen interact with the risk of collapse, and whether preventing atelectasis on imaging translates into fewer symptomatic complications, shorter stays and lower costs. But the study’s broader significance reaches beyond pediatric anesthesia. It is a reminder that in medicine the most consequential practices are often those so ingrained they escape notice — a knob turned out of habit, a ritual inherited without question. Every day, in thousands of operating rooms, that knob is turned. This trial asks what happens next, in the hours after the child leaves the operating room, when the alveoli are left to answer for it.

The importance of effective management of body temperature during FDG PET scans cannot be overstated. Pediatric patients are particularly susceptible to hypothermia, which can adversely affect diagnostic accuracy. The conventional approach has often involved warming techniques, which aim to counteract heat loss during imaging procedures. However, the study presented a novel angle by assessing how premedication with fentanyl might alter the metabolic processing of brown fat in these scenarios.

Fentanyl, a potent synthetic opioid, has become a common component of premedication protocols in pediatric anesthesia due to its efficacy in pain management and sedation. However, the research team sought to explore whether its inclusion would inadvertently impact the metabolic activity of brown fat—a type of adipose tissue that plays a critical role in maintaining body temperature by burning calories. Their hypothesis centered on whether fentanyl could either enhance or inhibit the uptake of FDG by brown fat during the warming process.

To investigate this hypothesis, the researchers conducted a series of controlled trials, administering fentanyl to a cohort of pediatric patients scheduled for FDG PET scans. Simultaneously, they measured the uptake of FDG in brown adipose tissue using advanced imaging techniques. The methodology was meticulous, ensuring that various variables such as age, weight, and baseline metabolic rates were adequately controlled to yield reliable results.

The findings revealed that the addition of fentanyl premedication had a statistically significant impact on brown fat uptake. Children who received fentanyl displayed altered patterns of FDG uptake compared to those who did not. These results suggest that fentanyl premedication may influence the metabolic response of brown adipose tissue during the procedural warming phase, potentially complicating the interpretation of PET scan results.

Moreover, the implications of this study extend beyond the immediate context of FDG PET imaging. The interaction between anesthetic agents and metabolic processes in brown fat opens new avenues for understanding how premedication can modulate energy expenditure in children. Given that childhood obesity is a growing public health concern, insights gleaned from this research could inform broader discussions about metabolic health and the management of pediatric patients under anesthesia.

The researchers emphasized the need for further studies to elucidate the underlying mechanisms by which fentanyl affects brown fat metabolism. Questions remain regarding the dosage required for optimal sedation without negatively impacting thermoregulation and metabolic processes. Furthermore, the study highlighted the necessity of individualized approaches to pediatric anesthetic practices, accounting for variability among children in terms of physiological responses to drugs.

In the context of the ongoing discussions about opioid use among pediatric populations, this research offers critical data that could inform safer anesthesia protocols. While fentanyl is effective, its potential effects on metabolic pathways must be carefully considered in clinical practice. As physicians weigh the benefits and risks of opioid premedication, the findings from this study could serve as a guiding framework for decision-making.

As the field of pediatric radiology continues to evolve, studies such as this underscore the importance of integrating basic science with clinical practice. The interplay between pharmacology and metabolism is intricate, necessitating a comprehensive understanding of how anesthetics can shape the physiological responses of young patients. Researchers encourage multidisciplinary collaborations to advance knowledge in this area, combining insights from radiology, anesthesiology, and pediatric care.

In conclusion, the study led by Lukulay et al. presents a compelling case for reevaluating anesthetic protocols involving fentanyl in pediatric settings. By showing that fentanyl premedication can impact brown fat uptake during a warming protocol for FDG PET, the research raises important questions about the implications for imaging practices and patient care. The results emphasize the need for continuous inquiry into the effects of medications used in pediatric anesthesia and their broader metabolic consequences.

As awareness of the intricacies of pediatric anesthesia grows, it is essential for clinicians to stay informed of emerging evidence. This research not only highlights a previously underexplored aspect of anesthetic practice but also calls for vigilance in ensuring that the safety and well-being of pediatric patients remain at the forefront of medical advancements.

Subject of Research: Impact of fentanyl premedication on brown fat uptake in children during FDG PET.

Article Title: Does the addition of fentanyl premedication impact brown fat uptake in children undergoing a warming protocol for FDG PET?

Article References:

Lukulay, M., Debnath, P., Anton, C. et al. Does the addition of fentanyl premedication impact brown fat uptake in children undergoing a warming protocol for FDG PET?.
Pediatr Radiol (2025). https://doi.org/10.1007/s00247-025-06381-5

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s00247-025-06381-5

Keywords: Pediatric Radiology, Brown Fat, Fentanyl, FDG PET, Anesthesia.